Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
29.31
-0.95 (-3.14%)
At close: Apr 25, 2024, 4:00 PM
28.38
-0.93 (-3.17%)
After-hours: Apr 25, 2024, 6:08 PM EDT
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $1.60 billion as of April 25, 2024. Its market cap has decreased by -18.68% in one year.
Market Cap
1.60B
Enterprise Value
1.38B
1-Year Change
-18.68%
Ranking
Category
Stock Price
$29.31
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $1.60B, an increase of 1,099.02%. That is a compound annual growth rate of 23.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 1.66B | 1.04% |
Apr 23, 2024 | 1.64B | 0.81% |
Apr 22, 2024 | 1.63B | 1.06% |
Apr 19, 2024 | 1.61B | 1.84% |
Apr 18, 2024 | 1.58B | -0.45% |
Apr 17, 2024 | 1.59B | -1.46% |
Apr 16, 2024 | 1.61B | -1.87% |
Apr 15, 2024 | 1.64B | -0.83% |
Apr 12, 2024 | 1.66B | -5.50% |
Apr 11, 2024 | 1.75B | 0.50% |
Apr 10, 2024 | 1.74B | 0.35% |
Apr 9, 2024 | 1.74B | 0.95% |
Apr 8, 2024 | 1.72B | -6.32% |
Apr 5, 2024 | 1.84B | 0.93% |
Apr 4, 2024 | 1.82B | -1.80% |
Apr 3, 2024 | 1.85B | 2.05% |
Apr 2, 2024 | 1.82B | -1.04% |
Apr 1, 2024 | 1.83B | -1.73% |
Mar 28, 2024 | 1.87B | 1.09% |
Mar 27, 2024 | 1.85B | 3.88% |
Mar 26, 2024 | 1.78B | -0.83% |
Mar 25, 2024 | 1.79B | -5.13% |
Mar 22, 2024 | 1.89B | -1.84% |
Mar 21, 2024 | 1.93B | 0.83% |
Mar 20, 2024 | 1.91B | -0.76% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ginkgo Bioworks Holdings | 1.67B |
Harmony Biosciences Holdings | 1.64B |
Myriad Genetics | 1.62B |
Inhibrx | 1.62B |
Avadel Pharmaceuticals | 1.61B |
UFP Technologies | 1.60B |
Taro Pharmaceutical Industries | 1.60B |
Zai Lab | 1.55B |